This Biotech Stock Surged with Fresh $9M Investment
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesA biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Dell Technologies is pursuing aggressive AI data center growth, backed by a sizable backlog, while HP Inc. grapples w...
Regulators are examining capital rules that could allow banks to take a bigger share of mortgage lending. Banks say c...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
A fintech platform unveils AI-driven index construction from a single prompt, with an uncapped 1% match for new membe...
A wave of selling in software names is prompting a rethinking of where capital flows. Market insiders say the episode...
Midwest apartment markets are turning brighter as rents rise and debt costs ease. BAM Capital now offers accredited i...
Markets pivot as inflation remains above target and energy prices climb. One economist warns the next time moves it’l...
CBS News confirmed it will shut down its CBS News Radio service by May 22, 2026, a move that ends a nearly 100-year e...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
Seven U.S. spot XRP ETFs have drawn $1.44B since late 2025, but XRP’s price remains volatile as inflows outpace gains.